RPRX

Royalty Pharma Plc

• TipRanks·1d ago

  Bank of America Securities Remains a Buy on Royalty Pharma (RPRX)

• NASDAQ·2d ago

  Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again

• Dow Jones·3d ago

  Royalty Pharma Is Maintained at Overweight by Morgan Stanley

• Benzinga·3d ago

  Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $67

• TipRanks·3d ago

  Royalty Pharma (RPRX) Gets a Buy from Morgan Stanley

• Seeking Alpha·10/03 13:34

  Revolution Medicines: Priced For A Label The Trial Didn't Test; Hold

• Benzinga·09/29 20:30

  If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today

• Simply Wall St·09/26 04:26

  Did AI Expansion Just Shift Royalty Pharma's (RPRX) Investment Narrative?

• TipRanks·09/24 09:30

  Analysts Offer Insights on Healthcare Companies: Royalty Pharma (RPRX), Travere Therapeutics (TVTX) and Veeva Systems (VEEV)

• Seeking Alpha·09/20 18:57

  FDA, Duke-Margolis workshop to examine evidence standards for rare diseases

• Simply Wall St·09/16 02:21

  Is Royalty Pharma (RPRX) Below Fair Value After The Pelacarsen Trial Miss?

• TipRanks·09/09 11:00

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• TipRanks·09/09 02:30

  Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

• Benzinga·09/08 21:30

  If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today

• Dow Jones·09/08 17:26

  Royalty Pharma Down Nearly 6%, on Pace for Largest Percent Decrease Since March 2025 -- Data Talk